Illegitimate online pharmacies are selling imatinib without a prescription, making false claims about being registered with regulatory bodies, and failing to provide patients with drug-related warnings.
Researchers sought to determine whether BMP4 levels would be predictive of outcomes in pediatric patients with B cell precursor acute lymphoblastic leukemia.
The mean total cost of care was $65,437 for blinatumomab, $55,995 for inotuzumab, and $17,520 for other agents.
Extended decitabine produced a similar overall survival rate as standard chemotherapy, but decitabine had a better safety profile.
Preliminary results of a clinical trial investigating the efficacy of CAR-T therapy in pediatric patients with CD7+ ALL/lymphoma were presented at ASCO 2022.